COREGCR (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the COREG drug offered from GlaxoSmithKline LLC. This Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | carvedilol phosphate |
| SUBSTANCE NAME: | CARVEDILOL PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-02-09 |
| END MARKETING DATE: | 0000-00-00 |
COREG CR HUMAN PRESCRIPTION DRUG Details:
| Item Description | COREG CR from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2007-02-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0007-3370_c4959761-0667-4cf6-bf8b-f45dfd7b90f3 |
| PRODUCT NDC: | 0007-3370 |
| APPLICATION NUMBER: | NDA022012 |
Other CARVEDILOL PHOSPHATE Pharmaceutical Manufacturers / Labelers:
